Alpha 2.0
Login Register
» Authors » Rene Pschowski

Rene Pschowski

Explore the profile of Rene Pschowski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 587
Followers 0
Related Specialties
Endocrinology
Critical Care
Emergency Medicine
Top 10 Co-Authors
Joerg C Schefold
Stephan von Haehling
Dietrich Hasper
Petra Reinke
Gerhard Fusch
Christina Fotopoulou
Bertram Wiedenmann
Hans-Dieter Volk
Marianne Pavel
Ulrich-Frank Pape
Published In
Neuroendocrinology
J Emerg Med
Nephrol Dial Transplant
Anticancer Res
J Comput Assist Tomogr
Affiliations
Soon will be listed here.
Recent Articles
1.
Prevalence, one-year-incidence and predictors of carcinoid heart disease
Mattig I, Franke M, Pschowski R, Brand A, Stangl K, Knebel F, et al.
Cardiovasc Ultrasound . 2023 Sep; 21(1):18. PMID: 37752548
Background: Carcinoid heart disease (CHD) caused by neuroendocrine tumours (NET) is associated with an increased morbidity and mortality due to valvular dysfunction and right sided heart failure. The present study...
2.
Increased urinary excretion of kynurenic acid is associated with non-recovery from acute kidney injury in critically ill patients
Aregger F, Uehlinger D, Fusch G, Bahonjic A, Pschowski R, Walter M, et al.
BMC Nephrol . 2018 Feb; 19(1):44. PMID: 29482511
Background: Acute kidney injury (AKI) is often observed in critically ill patients and is associated with high morbidity and mortality. Non-recovery from AKI has a negative impact on the prognosis...
3.
Influence of core body temperature on Tryptophan metabolism, kynurenines, and estimated IDO activity in critically ill patients receiving target temperature management following cardiac arrest
Schefold J, Fritschi N, Fusch G, Bahonjic A, Doehner W, von Haehling S, et al.
Resuscitation . 2016 Aug; 107:107-14. PMID: 27565863
Background/aims: Temperature control improves neurological prognosis in comatose cardiac arrest (CA) survivors. Previous reports demonstrate that most affected patients show signs of significant systemic inflammation. In an effort to better...
4.
Management of follow-up of neuroendocrine neoplasias
Pape U, Maasberg S, Jann H, Pschowski R, Kruger S, Prasad V, et al.
Best Pract Res Clin Endocrinol Metab . 2016 Mar; 30(1):129-40. PMID: 26971849
Neuroendocrine neoplasias (NEN) comprise heterogeneous epithelial neoplasms with a large variety of clinical presentations, treatment options and outcomes. Since potentially all NEN bear malignant potential it is important for long-term...
5.
Increased Activity of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia
Pschowski R, Pape U, Fusch G, Fischer C, Jann H, Baur A, et al.
Neuroendocrinology . 2016 Mar; 104(2):135-144. PMID: 26954941
Background/aims: Data from a considerable number of malignancies demonstrate that depletion of the essential amino acid tryptophan via induction of the immunoregulatory enzyme indoleamine-2,3-dioxygenase (IDO) serves as an important tumour...
6.
Maximizing Information From Routine Staging Computed Tomography in Functional Neuroendocrine Neoplasms: Are There Findings Indicating the Presence of Carcinoid Heart Disease?
Baur A, Kunz F, Schwenke C, Pschowski R, Ropke T, Pavel M, et al.
J Comput Assist Tomogr . 2016 Jan; 40(2):277-82. PMID: 26760186
Purpose: The aim of this study was to evaluate signs of right-sided heart dysfunction on staging computed tomography (CT) as indirect indicators of carcinoid heart disease. Patients And Methods: Patients...
7.
Staged Catheter-Based Valve Treatment of Severe Carcinoid Heart Disease
Laule M, Pschowski R, Pape U, Pavel M, Stangl V, Baumann G, et al.
Neuroendocrinology . 2015 Jul; 103(3-4):259-62. PMID: 26138598
Purpose: Carcinoid heart disease (CHD) with severe valve destruction represents the major cause of high morbidity and mortality in patients with carcinoid syndrome. In this paper, we present a novel...
8.
The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial
Schefold J, von Haehling S, Pschowski R, Bender T, Berkmann C, Briegel S, et al.
Crit Care . 2014 Jan; 18(1):R11. PMID: 24405734
Introduction: Acute renal failure (ARF) requiring renal replacement therapy (RRT) occurs frequently in ICU patients and significantly affects mortality rates. Previously, few large clinical trials investigated the impact of RRT...
9.
Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer
Fotopoulou C, Sehouli J, Pschowski R, von Haehling S, Domanska G, Braicu E, et al.
Anticancer Res . 2011 Jul; 31(8):2629-35. PMID: 21778315
Background/aim: Induction of tryptophan catabolism is mediated by inflammatory mechanisms including up-regulation of the immunoregulatory enzyme indoleamine-2,3-dioxygenase (IDO). This leads to the formation of mediators collectively referred to as kynurenines....
10.
Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock
Schefold J, Zeden J, Pschowski R, Hammoud B, Fotopoulou C, Hasper D, et al.
Scand J Infect Dis . 2009 Dec; 42(3):164-71. PMID: 19958238
The immunoregulatory enzyme indoleamine 2,3-dioxygenase (IDO) controls tryptophan metabolism and is induced by pro-inflammatory stimuli. We investigated whether immunostimulatory treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF) influences IDO activity and tryptophan...